Product Images Yasmin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Yasmin NDC 50419-402 by Bayer Healthcare Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Drospirenone and Ethinyl estradiol are two types of hormones used in combination to make birth control pills. They work together to prevent pregnancy by suppressing ovulation, thickening cervical mucus, and altering the lining of the uterus.*
This text describes different contraceptive methods and their effectiveness. It lists the different levels of pregnancies per 100 women using various methods, from less than 1 pregnancy to over 85 pregnancies. It also mentions the different types of birth control, including injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, condoms, diaphragm, spermicide, withdrawal, and no birth control. It suggests avoiding sex during the most fertile days of the monthly cycle and highlights the importance of contraception.*
This text appears to be a table that shows numerical ranges of blood clotting incidents among women with different conditions such as being pregnant, postpartum or not on COC (contraceptive pill). The table lists the number of women with blood clots per 10,000 women years. The footnote mentions that pregnancy data is based on actual duration and the given rate is calculated based on model assumption.*
This text provides information on the ranges of blood clot occurrence in different groups of women categorized based on their pregnancy status and contraceptive use. It includes a chart showing the number of women with a blood clot per 10,000 women-years in these groups. The data for pregnancy in the chart is based on the actual duration of pregnancy in reference studies, considering a model assumption that pregnancy duration is nine months.*
This text provides a list of relevant studies conducted on the risk of breast cancer associated with combined oral contraceptives. The studies include NICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses' Health Study Il, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The text also presents effect estimates in the form of OR, RR, and HR for different comparisons.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.